文献速递肺血管病与心包/心肌炎心力衰竭与心肌病

慢性血栓栓塞性肺动脉高压中的左心室充盈压

Left Ventricular Filling Pressure in Chronic Thromboembolic Pulmonary Hypertension.
PubMed 文献 · J Am Coll Cardiol · 2023-01-01

本研究纳入593例连续接受首次诊断性右心及左心导管检查的慢性血栓栓塞性肺动脉高压(CTEPH)患者,评估左心室充盈压(LVFP)升高的患病率及预后意义。结果显示LVFP>15 mm Hg者占10.6%,>11 mm Hg者占37.4%,两种阈值均与长期生存率较差相关。

要点

  • CTEPH患者中左心室充盈压升高常见,>15 mm Hg者占10.6%。
  • 心房颤动、钙化性主动脉瓣狭窄、二尖瓣反流及左心房容积是LVFP升高的独立决定因素。
  • LVFP>15 mm Hg和>11 mm Hg均与更差的长期生存相关。

核心结论

  • CTEPH患者中左心室充盈压升高常见,可能源于合并的左心疾病,并预测预后。

研究设计与样本

  • 本研究为观察性研究,纳入593例连续接受首次诊断性右心及左心导管检查的CTEPH患者。

主要发现

  • LVFP>15 mm Hg者63例(10.6%),>11 mm Hg者222例(37.4%)。
  • 单变量logistic回归分析识别年龄、系统性高血压、糖尿病、心房颤动、钙化性主动脉瓣狭窄、二尖瓣反流和左心房容积为LVFP升高的显著预测因素。
  • 调整分析中,心房颤动、钙化性主动脉瓣狭窄、二尖瓣反流和左心房容积仍是LVFP的独立决定因素。
  • 随访期间,接受肺动脉内膜剥脱术的患者LVFP更高(P = 0.002)。
  • LVFP>15 mm Hg(P = 0.021)和>11 mm Hg(P = 0.006)均与更差的长期生存相关。

关键数值与推荐

  • 主要分析采用mPAWP和/或LVEDP>15 mm Hg作为LVFP升高的阈值(依据当前肺动脉高压指南推荐)。
  • 次要分析采用mPAWP和/或LVEDP>11 mm Hg作为LVFP升高的阈值(代表正常上限)。

临床怎么用

  • 在CTEPH患者中应评估左心室充盈压,以识别合并左心疾病并指导预后判断。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Chronic thromboembolic pulmonary hypertension (CTEPH) is characterized by obstruction of major pulmonary arteries with organized thrombi. Clinical risk factors for pulmonary hypertension due to left heart disease including metabolic syndrome, left-sided valvular heart disease, and ischemic heart disease are common in CTEPH patients. OBJECTIVES: The authors sought to investigate prevalence and prognostic implications of elevated left ventricular filling pressures (LVFP) in CTEPH. METHODS: A total of 593 consecutive CTEPH patients undergoing a first diagnostic right and left heart catheterization were included in this study. Mean pulmonary arterial wedge pressure (mPAWP) and left ventricular end-diastolic pressure (LVEDP) were utilized for assessment of LVFP. Two cutoffs were applied to identify patients with elevated LVFP: 1) for the primary analysis mPAWP and/or LVEDP >15 mm Hg, as recommended by the current pulmonary hypertension guidelines; and 2) for the secondary analysis mPAWP and/or LVEDP >11 mm Hg, representing the upper limit of normal. Clinical and echocardiographic features, and long-term mortality were assessed. RESULTS: LVFP was >15 mm Hg in 63 (10.6%) and >11 mm Hg in 222 patients (37.4%). Univariable logistic regression analysis identified age, systemic hypertension, diabetes, atrial fibrillation, calcific aortic valve stenosis, mitral regurgitation, and left atrial volume as significant predictors of elevated LVFP. Atrial fibrillation, calcific aortic valve stenosis, mitral regurgitation, and left atrial volume remained independent determinants of LVFP in adjusted analysis. At follow-up, higher LVFPs were measured in patients who had meanwhile undergone pulmonary endarterectomy (P = 0.002). LVFP >15 mm Hg (P = 0.021) and >11 mm Hg (P = 0.006) were both associated with worse long-term survival. CONCLUSIONS: Elevated LVFP is common, appears to be due to comorbid left heart disease, and predicts prognosis in CTEPH.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Gerges C, Pistritto AM, Gerges M, et al. Left Ventricular Filling Pressure in Chronic Thromboembolic Pulmonary Hypertension. J Am Coll Cardiol. 2023. PMID: 36792280. doi:10.1016/j.jacc.2022.11.049

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。